Sifalimumab
Sifalimumab
Jump to navigation
Jump to search
 Fab fragment of sifalimumab bound to IFN-α2A. From PDB: 4ypg. | |
| Monoclonal antibody | |
|---|---|
| Type | Whole antibody |
| Source | Human |
| Target | Interferon α |
| Clinical data | |
| ATC code |
|
| Identifiers | |
| CAS Number |
|
| ChemSpider |
|
| UNII |
|
| KEGG |
|
| Chemical and physical data | |
| Formula | C6518H10008N1724O2032S38 |
| Molar mass | 146.25 kg/mol |
 N Y (what is this?) (verify) | |
Sifalimumab is a human monoclonal antibody designed for the treatment of SLE, dermatomyositis, and polymyositis. It targets interferon a.[1]
Sifalimumab was developed by MedImmune; as of 2017 development had been terminated in favor of moving a competing internal product, anifrolumab, into Phase III trials.[2][3][4]
References[edit]
^ "Statement On A Nonproprietary Name Adopted By The USAN Council: Sifalimumab" (PDF). American Medical Association..mw-parser-output cite.citationfont-style:inherit.mw-parser-output qquotes:"""""""'""'".mw-parser-output code.cs1-codecolor:inherit;background:inherit;border:inherit;padding:inherit.mw-parser-output .cs1-lock-free abackground:url("//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png")no-repeat;background-position:right .1em center.mw-parser-output .cs1-lock-limited a,.mw-parser-output .cs1-lock-registration abackground:url("//upload.wikimedia.org/wikipedia/commons/thumb/d/d6/Lock-gray-alt-2.svg/9px-Lock-gray-alt-2.svg.png")no-repeat;background-position:right .1em center.mw-parser-output .cs1-lock-subscription abackground:url("//upload.wikimedia.org/wikipedia/commons/thumb/a/aa/Lock-red-alt-2.svg/9px-Lock-red-alt-2.svg.png")no-repeat;background-position:right .1em center.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registrationcolor:#555.mw-parser-output .cs1-subscription span,.mw-parser-output .cs1-registration spanborder-bottom:1px dotted;cursor:help.mw-parser-output .cs1-hidden-errordisplay:none;font-size:100%.mw-parser-output .cs1-visible-errorfont-size:100%.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration,.mw-parser-output .cs1-formatfont-size:95%.mw-parser-output .cs1-kern-left,.mw-parser-output .cs1-kern-wl-leftpadding-left:0.2em.mw-parser-output .cs1-kern-right,.mw-parser-output .cs1-kern-wl-rightpadding-right:0.2em
^ "Press release: New Hope for Lupus Patients". MedImmune. 11 August 2015. Archived from the original on 31 July 2017.
^ "Sifalimumab". AdisInsight. Retrieved 31 July 2017.
^ "Sifalimumab". NHS Specialist Pharmacy Service. Retrieved 31 July 2017.
 | This monoclonal antibody-related article is a stub. You can help Wikipedia by expanding it. |
 | This antineoplastic or immunomodulatory drug article is a stub. You can help Wikipedia by expanding it. |
Categories:
- Drugs not assigned an ATC code
- Monoclonal antibodies
- Monoclonal antibody stubs
- Antineoplastic and immunomodulating drug stubs
(window.RLQ=window.RLQ||).push(function()mw.config.set("wgPageParseReport":"limitreport":"cputime":"0.492","walltime":"0.773","ppvisitednodes":"value":4227,"limit":1000000,"ppgeneratednodes":"value":0,"limit":1500000,"postexpandincludesize":"value":129859,"limit":2097152,"templateargumentsize":"value":2633,"limit":2097152,"expansiondepth":"value":16,"limit":40,"expensivefunctioncount":"value":1,"limit":500,"unstrip-depth":"value":1,"limit":20,"unstrip-size":"value":10026,"limit":5000000,"entityaccesscount":"value":1,"limit":400,"timingprofile":["100.00% 651.923 1 -total"," 80.17% 522.632 1 Template:Drugbox"," 60.38% 393.630 1 Template:Infobox"," 11.18% 72.865 4 Template:Cite_web"," 9.36% 60.998 16 Template:Unbulleted_list"," 6.79% 44.264 1 Template:Infobox_drug/chemical_formula"," 6.46% 42.126 9 Template:Navbox"," 2.89% 18.810 1 Template:Monoclonals_for_immune_system"," 2.33% 15.210 1 Template:Cytokine_receptor_modulators"," 2.30% 14.966 1 Template:Chem_molar_mass"],"scribunto":"limitreport-timeusage":"value":"0.171","limit":"10.000","limitreport-memusage":"value":4227874,"limit":52428800,"cachereport":"origin":"mw1273","timestamp":"20181011011350","ttl":1900800,"transientcontent":false);mw.config.set("wgBackendResponseTime":80,"wgHostname":"mw1326"););
Clash Royale CLAN TAG